BioCentury
ARTICLE | Clinical News

Insmed reports mixed diabetes data

November 27, 2000 8:00 AM UTC

INSM said that in a Phase II study of 246 Type II diabetes patients, the combination of its INS-1 D-chiro-inositol insulin sensitizer and sulfonylureas showed no statistically significant difference c...